サマリー

神経科学の抗体とアッセイの世界市場 2024-2028
神経科学の抗体およびアッセイ市場は、2023-2028年に22億米ドル成長し、予測期間中のCAGRは9.64%で加速すると予測されます。当レポートでは、神経科学の抗体およびアッセイ市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の増加、政府や医療機関からの取り組みや支援の増加、抗体製造の技術進歩などが市場を牽引しています。
Technavio社の神経科学分野の抗体・アッセイ市場は以下のように分類されています：
タイプ別
- 消耗品
- 器具
用途別
- 製薬・バイオ製薬企業
- 学術・研究機関
- 病院・診断センター
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、臨床試験の増加が、今後数年間の神経科学抗体・アッセイ市場の成長を促進する主な理由の1つであると特定している。また、リキッドバイオプシーの出現とシングルセル分析技術の採用の増加は、市場の大きな需要につながる。
本レポートでは、神経科学の抗体およびアッセイ市場について、以下の分野をカバーしています：
- 神経科学の抗体とアッセイ市場のサイジング
- ニューロサイエンスの抗体とアッセイ市場予測
- 神経科学用抗体およびアッセイ市場の産業分析
本レポートでは、神経科学用抗体およびアッセイ市場の主要ベンダー（Abcam plc、Abnova Corp.、Bio Rad Laboratories Inc.、Biosensis Pty Ltd.、BMG LABTECH GmbH、Cell Signaling Technology Inc、Chemie Brunschwig AG、Elabscience Biotechnology Inc.、Enzo Biochem Inc.、F. Hoffmann La Roche Ltd.、Fujirebio Holdings Inc.、GenScript Biotech Corp.、Kaneka Corp.、Merck KGaA、NSJ Bioreagents、PerkinElmer Inc.、Proteintech Group Inc.、Rockland Immunochemicals Inc.、Santa Cruz Biotechnology Inc.、Thermo Fisher Scientific Inc.また、神経科学の抗体およびアッセイ市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neuroscience-antibodies-and-assays-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global neuroscience antibodies and assays market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global neuroscience antibodies and assays market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Consumables - Market size and forecast 2023-2028
o Exhibit 34: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Consumables - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
o 6.4 Instruments - Market size and forecast 2023-2028
o Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
o Exhibit 48: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
o 7.4 Academic and research institutes - Market size and forecast 2023-2028
o Exhibit 52: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
o 7.5 Hospital and diagnostic centers - Market size and forecast 2023-2028
o Exhibit 56: Chart on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ billion)
o Exhibit 61: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abcam plc
o Exhibit 111: Abcam plc - Overview
o Exhibit 112: Abcam plc - Product / Service
o Exhibit 113: Abcam plc - Key news
o Exhibit 114: Abcam plc - Key offerings
o 12.4 Abnova Corp.
o Exhibit 115: Abnova Corp. - Overview
o Exhibit 116: Abnova Corp. - Product / Service
o Exhibit 117: Abnova Corp. - Key offerings
o 12.5 Bio Rad Laboratories Inc.
o Exhibit 118: Bio Rad Laboratories Inc. - Overview
o Exhibit 119: Bio Rad Laboratories Inc. - Business segments
o Exhibit 120: Bio Rad Laboratories Inc. - Key news
o Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
o 12.6 BMG LABTECH GmbH
o Exhibit 123: BMG LABTECH GmbH - Overview
o Exhibit 124: BMG LABTECH GmbH - Product / Service
o Exhibit 125: BMG LABTECH GmbH - Key offerings
o 12.7 Cell Signaling Technology Inc.
o Exhibit 126: Cell Signaling Technology Inc. - Overview
o Exhibit 127: Cell Signaling Technology Inc. - Product / Service
o Exhibit 128: Cell Signaling Technology Inc. - Key offerings
o 12.8 Chemie Brunschwig AG
o Exhibit 129: Chemie Brunschwig AG - Overview
o Exhibit 130: Chemie Brunschwig AG - Product / Service
o Exhibit 131: Chemie Brunschwig AG - Key offerings
o 12.9 Elabscience Biotechnology Inc.
o Exhibit 132: Elabscience Biotechnology Inc. - Overview
o Exhibit 133: Elabscience Biotechnology Inc. - Product / Service
o Exhibit 134: Elabscience Biotechnology Inc. - Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Fujirebio Holdings Inc.
o Exhibit 140: Fujirebio Holdings Inc. - Overview
o Exhibit 141: Fujirebio Holdings Inc. - Product / Service
o Exhibit 142: Fujirebio Holdings Inc. - Key offerings
o 12.12 GenScript Biotech Corp.
o Exhibit 143: GenScript Biotech Corp. - Overview
o Exhibit 144: GenScript Biotech Corp. - Business segments
o Exhibit 145: GenScript Biotech Corp. - Key news
o Exhibit 146: GenScript Biotech Corp. - Key offerings
o Exhibit 147: GenScript Biotech Corp. - Segment focus
o 12.13 Merck KGaA
o Exhibit 148: Merck KGaA - Overview
o Exhibit 149: Merck KGaA - Business segments
o Exhibit 150: Merck KGaA - Key news
o Exhibit 151: Merck KGaA - Key offerings
o Exhibit 152: Merck KGaA - Segment focus
o 12.14 PerkinElmer Inc.
o Exhibit 153: PerkinElmer Inc. - Overview
o Exhibit 154: PerkinElmer Inc. - Business segments
o Exhibit 155: PerkinElmer Inc. - Key news
o Exhibit 156: PerkinElmer Inc. - Key offerings
o Exhibit 157: PerkinElmer Inc. - Segment focus
o 12.15 Rockland Immunochemicals Inc.
o Exhibit 158: Rockland Immunochemicals Inc. - Overview
o Exhibit 159: Rockland Immunochemicals Inc. - Product / Service
o Exhibit 160: Rockland Immunochemicals Inc. - Key offerings
o 12.16 Santa Cruz Biotechnology Inc.
o Exhibit 161: Santa Cruz Biotechnology Inc. - Overview
o Exhibit 162: Santa Cruz Biotechnology Inc. - Product / Service
o Exhibit 163: Santa Cruz Biotechnology Inc. - Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 164: Thermo Fisher Scientific Inc. - Overview
o Exhibit 165: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 166: Thermo Fisher Scientific Inc. - Key news
o Exhibit 167: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 168: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global neuroscience antibodies and assays market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Instruments - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Instruments - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Application - Market share 2023-2028 (%)
Exhibits45: Data Table on Application - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Hospital and diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Hospital and diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Application ($ billion)
Exhibits61: Data Table on Market opportunity by Application ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abcam plc - Overview
Exhibits112: Abcam plc - Product / Service
Exhibits113: Abcam plc - Key news
Exhibits114: Abcam plc - Key offerings
Exhibits115: Abnova Corp. - Overview
Exhibits116: Abnova Corp. - Product / Service
Exhibits117: Abnova Corp. - Key offerings
Exhibits118: Bio Rad Laboratories Inc. - Overview
Exhibits119: Bio Rad Laboratories Inc. - Business segments
Exhibits120: Bio Rad Laboratories Inc. - Key news
Exhibits121: Bio Rad Laboratories Inc. - Key offerings
Exhibits122: Bio Rad Laboratories Inc. - Segment focus
Exhibits123: BMG LABTECH GmbH - Overview
Exhibits124: BMG LABTECH GmbH - Product / Service
Exhibits125: BMG LABTECH GmbH - Key offerings
Exhibits126: Cell Signaling Technology Inc. - Overview
Exhibits127: Cell Signaling Technology Inc. - Product / Service
Exhibits128: Cell Signaling Technology Inc. - Key offerings
Exhibits129: Chemie Brunschwig AG - Overview
Exhibits130: Chemie Brunschwig AG - Product / Service
Exhibits131: Chemie Brunschwig AG - Key offerings
Exhibits132: Elabscience Biotechnology Inc. - Overview
Exhibits133: Elabscience Biotechnology Inc. - Product / Service
Exhibits134: Elabscience Biotechnology Inc. - Key offerings
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: Fujirebio Holdings Inc. - Overview
Exhibits141: Fujirebio Holdings Inc. - Product / Service
Exhibits142: Fujirebio Holdings Inc. - Key offerings
Exhibits143: GenScript Biotech Corp. - Overview
Exhibits144: GenScript Biotech Corp. - Business segments
Exhibits145: GenScript Biotech Corp. - Key news
Exhibits146: GenScript Biotech Corp. - Key offerings
Exhibits147: GenScript Biotech Corp. - Segment focus
Exhibits148: Merck KGaA - Overview
Exhibits149: Merck KGaA - Business segments
Exhibits150: Merck KGaA - Key news
Exhibits151: Merck KGaA - Key offerings
Exhibits152: Merck KGaA - Segment focus
Exhibits153: PerkinElmer Inc. - Overview
Exhibits154: PerkinElmer Inc. - Business segments
Exhibits155: PerkinElmer Inc. - Key news
Exhibits156: PerkinElmer Inc. - Key offerings
Exhibits157: PerkinElmer Inc. - Segment focus
Exhibits158: Rockland Immunochemicals Inc. - Overview
Exhibits159: Rockland Immunochemicals Inc. - Product / Service
Exhibits160: Rockland Immunochemicals Inc. - Key offerings
Exhibits161: Santa Cruz Biotechnology Inc. - Overview
Exhibits162: Santa Cruz Biotechnology Inc. - Product / Service
Exhibits163: Santa Cruz Biotechnology Inc. - Key offerings
Exhibits164: Thermo Fisher Scientific Inc. - Overview
Exhibits165: Thermo Fisher Scientific Inc. - Business segments
Exhibits166: Thermo Fisher Scientific Inc. - Key news
Exhibits167: Thermo Fisher Scientific Inc. - Key offerings
Exhibits168: Thermo Fisher Scientific Inc. - Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations